This message was sent to ##Email##
|
|
|
AST
The 2019 Cutting Edge of Transplantation (CEoT) meeting will be held Feb. 21-23 in Phoenix, AZ. Join us for this intimate meeting on personalized medicine.
READ MORE
OPTN/UNOS
OPTN/UNOS is offering nine proposals for public comment. You are encouraged to post comments on their website during the public comment period that runs January 22 – March 22, 2019. Your voice is important and considered during the OPTN/UNOS policy development process. During the public comment period, UNOS offers national webinars to provide members an opportunity to learn about proposals on the upcoming regional meeting agenda and ask questions of presenters/subject matter experts. For information about these webinars, click here.
The COPs will be reviewing the proposals and providing feedback for the AST's Policy Committee to develop a Society response for Board approval. If you would like to also submit your individual comments to AST for consideration as part of this process, please email them to scovington@myast.org with the subject line PUBLIC COMMENT.
AST
The AST and ASTS seek candidates for the position of Editor in Chief of the American Journal of Transplantation (AJT). AJT is a monthly, peer reviewed journal dedicated to advancing the science and practice of organ transplantation worldwide by reporting novel and rigorous research. Candidates should possess broad knowledge and experience of organ transplantation and have a distinguished record of scholarly achievement in addition to demonstrated leadership qualities, intellectual vision, outstanding organizational skills, and experience relevant to editing a leading scientific medical journal. The five-year compensated term will start no later than Aug. 1, 2020.
READ MORE
 |
|
The Thompson Liver / Oncology System provides surgeons with the ability to obtain stable, versatile retraction for liver transplants, liver resections, oncology, and obesity cases. Multi-planed retraction and unlimited flexibility for the most complex abdominal and pelvic cases. Call 1-800-227-7543 to start your free trial.
|
|
AST
The AST sponsors a variety of Achievement Awards in recognition of AST members' achievements and contributions to the field of transplantation. The AST encourages members to nominate deserving candidates for consideration. Make your nominations by January 31.
READ MORE
AST
Submit your nomination today for the AST's Transplant Advocacy Award, which honors an individual's contributions and advocacy efforts to improve the transplant community. To review the eligibility criteria and application requirements, click here.
|
The first and only clinically and analytically validated blood test that measures donor-derived cell-free DNA (dd-cfDNA), a direct indicator of kidney injury
Covered by Medicare
AlloSure 101 – Development & Summary Webinar – view
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
AST
As an AST member, access to free or discounted educational resources are included in your membership. These diverse educational resources offer materials relevant to the transplant professional in every stage of their career – from basic trainee lessons to webinars on specialized topics. LEARN MORE
AST
Comprehensive Trainee Curriculum (CTC) is a great way to expand your transplant knowledge. This feature is an online educational platform that features dozens of webinars on various concentrations of transplantation.
READ MORE
Upcoming Education Events
|
   |
AST
Targeted Delivery of Immune Therapeutics to Lymph Nodes Prolongs Cardiac Allograft Survival
February 12, 2019 | 2 pm ET | Online Activity
For more information, click here.
Which Live Donor Kidney is Better?
February 20, 2019 | 2 pm ET | Online Activity
For more information, click here.
AST
The Thomas E. Starzl Transplantation Institute is accepting nominations for the 2020 Thomas E. Starzl Prize in Surgery and Immunology, awarded annually to a national or international leader in the field of organ transplantation and immunology. The prize consists of a crystal award, an honorarium of $10,000, and travel expenses to the University of Pittsburgh School of Medicine in the spring of 2020 to formally receive the award and to present the Thomas E. Starzl Prize in Surgery and Immunology lecture. The winner will also participate in related activities and meet informally with faculty, post-doctoral fellows and students.
READ MORE
AST
The Pediatric, Infectious Disease, and Transplant Pharmacy COPs created a flyer that provides information for transplant recipients about the flu vaccine.
READ MORE
ASTS
The goal of the ASTS Cellular Transplantation Committee is to advance the knowledge and promote clinical and research work in the field of cellular transplantation. One of this year’s initiatives that was set forward by the ASTS Cellular Transplantation Committee is to conduct the survey of ongoing research and clinical work in the areas of cellular products and therapies. The purpose of the project is to assess areas of interest of research within the transplant community. This survey should take approximately 10 minutes.
READ MORE
The articles included in this email are for informational use only and are not endorsed by the AST.
|
American Journal of Transplantation
The pre‐listing variables essential for creating an accurate heart transplant allocation score based on survival are unknown. To identify these we studied mortality of adults on the active heart transplant waiting list in the Scientific Registry of Transplant Recipients database from January 1, 2004‐August 31, 2015. There were 33,069 candidates awaiting heart transplantation: 7,681 UNOS Status 1A, 13,027 Status 1B, and 12,361 Status 2.
READ MORE
American Journal of Transplantation
We aimed to determine if the severity of computed tomographic coronary angiography (CTCA)‐diagnosed CAD is associated with post‐liver transplantation (LT) myocardial infarction (MI) within 30 days and early mortality. We retrospectively evaluated 2,118 consecutive patients who underwent CAD screening using CTCA. Post‐LT type‐2‐MI, elicited by oxygen supply‐and‐demand mismatch within a month after LT, was assessed according to the severity of CTCA‐diagnosed CAD.
READ MORE
American Journal of Transplantation
Noninvasive biomarkers are needed to monitor stable patients after kidney transplant (KT), because subclinical acute rejection (subAR), currently detectable only with surveillance biopsies, can lead to chronic rejection and graft loss. We conducted a multicenter study to develop a blood‐based molecular biomarker for subAR using peripheral blood paired with surveillance biopsies and strict clinical phenotyping algorithms for discovery and validation.
READ MORE
Transplantation
Nonalcoholic steatohepatitis (NASH)-related cirrhosis has become one of the most common indications for liver transplantation (LT), particularly in candidates older than 65 years. Typically, NASH candidates have concurrent obesity, metabolic, and cardiovascular risks, which directly impact patient evaluation and selection, waitlist morbidity and mortality, and eventually posttransplant outcomes. The purpose of these guidelines is to highlight specific features commonly observed in NASH candidates and strategies to optimize pretransplant evaluation and waitlist survival.
READ MORE
Transplantation
Tuberculosis (TB) is a significant opportunistic infection in solid organ transplant recipients (SOTR). There are limited data on TB incidence in transplantation from low prevalence countries as well as on long-term TB-specific immune responses. We performed a single-center retrospective review of SOTR diagnosed with active TB between 2000 and 2015 and further contacted the available patients for a study of long-term T-cell responses using an interferon-gamma (IFN-γ) release assay and a flow cytometry-based assay.
READ MORE
|
|
|
 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|